G. Walmsley Graham - Net Worth and Insider Trading
G. Walmsley Graham Net Worth
The estimated net worth of G. Walmsley Graham is at least $38 Million dollars as of 2024-11-28. G. Walmsley Graham is the Director of Akero Therapeutics Inc and owns about 802,168 shares of Akero Therapeutics Inc (AKRO) stock worth over $26 Million. G. Walmsley Graham is the Director of Olema Pharmaceuticals inc and owns about 708,114 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $7 Million. G. Walmsley Graham is also the Director of ALX Oncology Holdings Inc and owns about 3,156,981 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $5 Million. Details can be seen in G. Walmsley Graham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that G. Walmsley Graham has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of G. Walmsley Graham
G. Walmsley Graham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, G. Walmsley Graham owns 4 companies in total, including ALX Oncology Holdings Inc (ALXO) , Akero Therapeutics Inc (AKRO) , and Olema Pharmaceuticals inc (OLMA) among others .
Click here to see the complete history of G. Walmsley Graham’s form 4 insider trades.
Insider Ownership Summary of G. Walmsley Graham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-12-14 | director |
| AKRO | Akero Therapeutics Inc | 2023-12-08 | director |
| OLMA | Olema Pharmaceuticals inc | 2024-06-04 | director |
 | | 2020-11-20 | director |
G. Walmsley Graham Latest Holdings Summary
G. Walmsley Graham currently owns a total of 3 stocks. Among these stocks, G. Walmsley Graham owns 802,168 shares of Akero Therapeutics Inc (AKRO) as of December 8, 2023, with a value of $26 Million and a weighting of 68.38%. G. Walmsley Graham owns 708,114 shares of Olema Pharmaceuticals inc (OLMA) as of June 4, 2024, with a value of $7 Million and a weighting of 18.99%. G. Walmsley Graham also owns 3,156,981 shares of ALX Oncology Holdings Inc (ALXO) as of December 14, 2020, with a value of $5 Million and a weighting of 12.63%.
Latest Holdings of G. Walmsley Graham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2023-12-08 | 802,168 | 32.17 | 25,805,745 |
| OLMA | Olema Pharmaceuticals inc | 2024-06-04 | 708,114 | 10.12 | 7,166,114 |
| ALXO | ALX Oncology Holdings Inc | 2020-12-14 | 3,156,981 | 1.51 | 4,767,041 |
Holding Weightings of G. Walmsley Graham
G. Walmsley Graham Form 4 Trading Tracker
According to the SEC Form 4 filings, G. Walmsley Graham has made a total of 6 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Akero Therapeutics Inc is the acquisition of 100,000 shares on December 8, 2023, which cost G. Walmsley Graham around $2 Million.
According to the SEC Form 4 filings, G. Walmsley Graham has made a total of 4 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 1,175,000 shares on June 4, 2024, which brought G. Walmsley Graham around $17 Million.
According to the SEC Form 4 filings, G. Walmsley Graham has made a total of 2 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 20,000 shares on December 14, 2020, which cost G. Walmsley Graham around $2 Million.
Insider Trading History of G. Walmsley Graham
- 1
G. Walmsley Graham Trading Performance
GuruFocus tracks the stock performance after each of G. Walmsley Graham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by G. Walmsley Graham is 0.81%. GuruFocus also compares G. Walmsley Graham's trading performance to market benchmark return within the same time period. The performance of stocks bought by G. Walmsley Graham within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how G. Walmsley Graham's insider trading performs compared to the benchmark.
Performance of G. Walmsley Graham
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.09 | | | | | |
| Relative Return to S&P 500(%) | 12.12 | | | | | |
G. Walmsley Graham Ownership Network
G. Walmsley Graham Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
G. Walmsley Graham is the director of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, G. Walmsley Graham made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .
In summary, during the past 3 months, insiders sold 0 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
G. Walmsley Graham Mailing Address
Above is the net worth, insider trading, and ownership report for G. Walmsley Graham. You might contact G. Walmsley Graham via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
